Imspex Diagnostics Renews ISO 13485 Certification
Imspex Diagnostics Ltd has announced the successful renewal of its ISO 13485:2016 certification, reaffirming its commitment to quality, regulatory compliance, and the delivery of reliable diagnostic technologies. This milestone reflects the strength of the company’s quality management systems across design, development, and manufacturing, and provides a solid foundation for the continued advancement of its next-generation, […]
GC-IMS – Seeing molecules differently
Why GC-IMS is becoming the platform for rapid VOC intelligence Volatile organic compounds carry information — about flavour, contamination, process drift, safety, and biological state.The challenge has always been extracting that information quickly, robustly, and outside specialist laboratories. GC-IMS changes that equation. By coupling fast gas chromatography with ion mobility spectrometry, GC-IMS delivers: GC-IMS routinely […]
Academic & Research
A new analytical workhorse for VOC-driven research GC-IMS is rapidly becoming a powerful research platform across:• Food science• Microbial metabolomics• Environmental chemistry• Biomedical VOC diagnostics Peer-reviewed studies show GC-IMS:• Detects microbial VOCs directly from blood-culture headspace• Identifies characteristic VOC marker patterns from microorganisms already present or actively growing• Provides rapid, high-throughput metabolomic fingerprints With two-dimensional […]
Recent Grant Success: Strengthening Our Growth and Capability
Imspex Diagnostics is pleased to confirm that we have secured further support through the Welsh Government SMART Digital and Productivity Accelerator programme, recognising the company’s continued progress and growth potential. This award reflects confidence in Imspex as an innovation-led business delivering advanced analytical technology across healthcare, industry and security sectors. The programme will support an […]
Grant Highlight: TOXI-Triage
Imspex Diagnostics was a funded partner in the EU Horizon TOXI-Triage programme, a major European initiative focused on improving response capability during chemical and toxic exposure incidents. The project brought together emergency responders, research organisations and technology developers to advance faster, field-deployable triage and detection tools. Through TOXI-Triage, Imspex’s GC-IMS technology platform was validated for […]
Grant Highlight: ONELAB Project
Imspex Diagnostics was selected for the OneLab project, a collaborative initiative designed to accelerate the deployment of advanced analytical technologies into real-world environments. The programme brings together technology developers, laboratories and end-users to validate performance, refine workflows and demonstrate operational impact. Our inclusion reflects both the strength of the Imspex GC-IMS technology platform and our […]
Imspex at World Health Expo Dubai 2026
Imspex is exhibiting at the World Health Expo Dubai from Monday 9 – Thursday 12 February 2026, and we are based on the Welsh Pavilion at Stand S9.A50. As part of the Wales delegation, we’re looking forward to a busy week of meetings, networking and discussions with partners, distributors, clinicians and organisations interested in advanced […]
Business Development (Analytical Chemistry / Biology / Instrumentation)
Imspex Diagnostics is expanding its commercial team and we’re looking for a standout Business Development professional with a proven track record in analytical instrumentation. You’ll already be confident selling platforms such as HPLC, LC-MS, GC, GC-MS, SPE, Flash, ICP, and Purification systems, and you know how to engage technically minded customers across clinical and industry […]
Imspex joins the Welsh Delegation at MEDICA 2025
Imspex Diagnostics joins Welsh Delegation at MEDICA, Düsseldorf Next week, Amber Jacobs, PR, Marketing & ESG Compliance Leader at Imspex Diagnostics, will be joining the Welsh Government’s life sciences delegation at MEDICA 2025 in Düsseldorf. MEDICA is one of the world’s largest trade fairs for medical technology, diagnostics, and healthcare innovation. Amber will represent Imspex […]
Imspex Diagnostics at LSX Investival 2025
Imspex Diagnostics at LSX Investival Showcase, London Imspex Diagnostics CEO John McKinley and CFO Toby Wilson Waterworth will be attending the LSX Investival Showcase in London next week. The event brings together leaders from across the life sciences and investment communities to share innovation, insights, and opportunities for collaboration. John and Toby will be meeting […]
Imspex at the IABR Summit 2025
Representing Imspex Diagnostics at the forefront of global breath research Our Senior Research Scientist & Technical Support, Hannah Deane-Cutler, recently attended the International Association of Breath Research (IABR) Summit 2025 in Innsbruck, Austria. The event gathered researchers, clinicians, and industry leaders to share the latest developments in breath analysis across oncology, infectious diseases, gastrointestinal disorders, […]
Imspex to Present at BioSeed 2025
We’re pleased to share that Imspex Diagnostics will be represented at BioSeed 2025, taking place on 9 June in London. Hosted by OBN, BioSeed is a high-impact investment event that brings together early-stage R&D companies and a room full of active life sciences investors. John McKinley, our CEO & Director, will be presenting at the […]